Elyse Hanly, MD
Otolaryngology · Iowa City, IANPI 1740718931
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 54.8% of the total. Reporting peaked in 2022 at $1,296 and has fallen 82.5% since, to $227 in 2025.
Across 40 payments — averaging $52.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Sanofi$220
- Regeneron Healthcare Solutions, Inc.$177
- Integra Lifesciences Corporation$173
- Organogenesis Inc.$64
- Acclarent, Inc$63
- plus $257 from 8 others
What the payments were for
- Travel & lodging$1,15555%
- Food & beverage$95445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $1,155 |
| Sanofi | 13 | $220 |
| Regeneron Healthcare Solutions, Inc. | 9 | $177 |
| Integra Lifesciences Corporation | 1 | $173 |
| Organogenesis Inc. | 4 | $64 |
| Acclarent, Inc | 1 | $63 |
| Smith+Nephew | 2 | $58 |
| Convatec Inc. | 2 | $50 |
| Stryker | 1 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Greer Laboratories, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,109 in reported general payments places this provider in the 70th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 28 | $3,478 |
| Ipratropium Bromide | 49 | $2,174 |
| Epinephrine | 11 | $1,990 |
| Fluticasone Propionate | 115 | $1,621 |
| Azelastine Hcl | 35 | $709 |
| Ofloxacin | 44 | $603 |
| Lansoprazole | 33 | $561 |
| Omeprazole | 51 | $463 |
| Pantoprazole Sodium | 56 | $427 |
| Levothyroxine Sodium | 36 | $312 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $231 |
| Famotidine | 54 | $222 |
| Betamethasone Valerate | 21 | $211 |
| Triamcinolone Acetonide | 12 | $165 |
| Mupirocin | 16 | $127 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Iowa City
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Brian AndrewsIowa City$9K
- Douglas BennionIowa City$6K
- Grace NimmonsIowa City$4K
- Henry HoffmanIowa City$4K
- Michael ReedIowa City$3K
- Zaid Al-QurayshiIowa City$3K
- Megan JensenIowa City$2K
- Prashanth PrabakaranIowa City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.